Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs ...

This newly published review article offers a comprehensive examination of the complexities of tumor angiogenesis and the origins of endothelial cells (ECs) within tumors. Tumor angiogenesis, a ...

A new drug candidate has been developed that simultaneously blocks the proteins regulating cancer growth and metastasis. In ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, helping ...

This post was updated March 31 at 11:21 p.m. UCLA researchers developed a human stem cell-derived cell therapy for an ...

Researcher at Harvard Medical School develops AI-driven molecule targeting tumor mitochondria defects to destroy cancer ...

Checkpoint inhibitors have transformed cancer treatment over the past decade, helping hundreds of thousands of patients by ...